FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition,differing by the fact that a nanocapsule core is aspirin, and a coating is sodium alginate deposited from butanol suspension by adding carbon tetrachloride as a non-solvent and water that is followed by drying at room temperature.
EFFECT: invention provides simplifying and accelerating the nanoencapsulation process, reducing accompanying loss (higher weight yield).
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING ASPIRIN NANOCAPSULES IN CARRAGEENAN | 2014 |
|
RU2558084C1 |
METHOD OF PRODUCTION OF NANOCAPSULES OF ASPIRIN IN SODIUM ALGINATE | 2014 |
|
RU2557941C1 |
METHOD OF PRODUCTION OF RUSOVOSTATIN NANOCAPSULES IN SODIUM ALGINATE | 2014 |
|
RU2566712C1 |
METHOD OF ENCAPSULATION ASPIRIN IN XANTHAN GUM | 2014 |
|
RU2561686C1 |
METHOD OF PRODUCING ASPIRIN NANOCAPSULES IN SODIUM ALGINATE | 2014 |
|
RU2619329C2 |
METHOD OF PRODUCING FENBENDAZOLE NANOCAPSULES | 2014 |
|
RU2550923C1 |
METHOD OF PRODUCING RESVERATROL NANOCAPSULES IN PECTIN | 2014 |
|
RU2558079C1 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2538667C1 |
METHOD OF PRODUCTION OF ALBENDAZOLE NANOCAPSULES | 2014 |
|
RU2554783C1 |
METHOD OF PRODUCING NANOCAPSULES OF RESVERATROL IN SODIUM ALGINATE | 2014 |
|
RU2569734C2 |
Authors
Dates
2015-10-20—Published
2014-04-01—Filed